Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Ikeda, Keiichi ^a   Fujioka, Kouki ^a   Manome, Yoshinobu ^a   Tojo, Katsuyoshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; UROCORTIN; UROCORTIN I; UROCORTIN II; UROCORTIN III;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CONGESTIVE CARDIOMYOPATHY; DRUG MECHANISM; HEART FAILURE; HEART PROTECTION; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 84861018495     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/198628     Document Type: Review

References (69)

1. Grunt M., Glaser J., Schmidhuber H., Pauschinger P., Born J., Effects of corticotropin-releasing factor on isolated rat heart activity American Journal of Physiology 1993 264 4 H1124 H1129
2. Grunt M., Haug C., Duntas L., Pauschinger P., Maier V., Pfeiffer E. F., Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release Hormone and Metabolic Research 1992 24 2 56 59
3. Fisher L. A., Rivier J., Rivier C., Spiess J., Vale W., Brown M. R., Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats Endocrinology 1982 110 6 2222 2224
4. Fisher L. A., Jessen G., Brown M. R., Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate Regulatory Peptides 1983 5 2 153 161 (Pubitemid 13155963)
5. Kiang J. G., Wei E. T., CRF-evoked bradycardia in urethane-anesthetized rats is blocked by naloxone Peptides 1985 6 3 409 413 (Pubitemid 16255652)
6. Vale W., Spiess J., Rivier C., Rivier J., Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and -endorphin Science 1981 213 4514 1394 1397 (Pubitemid 12243637)
7. Hermus A. R., Pieters G. F., Willemsen J. J., Hypotensive effects of ovine and human corticotrophin-releasing factors in man European Journal of Clinical Pharmacology 1987 31 5 531 534 (Pubitemid 17016931)
8. Saitoh M., Hasegawa J., Mashiba H., Effect of corticotropin-releasing factor on the electrical and mechanical activities of the guinea-pig ventricular myocardium General Pharmacology 1990 21 3 337 342 (Pubitemid 20143152)
9. Haug C., Grunt M., Schmid S., Steinbach G., Metzele A., Maier V., Keck F. S., Grunert A., Effect of corticotropin releasing factor on atrial natriuretic peptide release from the isolated perfused rat heart Arzneimittel-Forschung 1994 44 5 579 582 (Pubitemid 24179878)
10. Lovenberg T. W., Chalmers D. T., Liu C., De Souza E. B., CRF2 and CRF2 receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues Endocrinology 1995 136 9 4139 4142
11. Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B., Oltersdorf T., Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain Proceedings of the National Academy of Sciences of the United States of America 1995 92 3 836 840
12. Stenzel P., Kesterson R., Yeung W., Cone R. D., Rittenberg M. B., Stenzel-Poore M. P., Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart Molecular Endocrinology 1995 9 5 637 645
13. Kishimoto T., Pearse R. V. II, Lin C. R., Rosenfeld M. G., A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle Proceedings of the National Academy of Sciences of the United States of America 1995 92 4 1108 1112
14. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., Vale W., Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart Proceedings of the National Academy of Sciences of the United States of America 1995 92 7 2969 2973
15. Vauhan J., Donaldson C., Bittencourt J., Perrin M. H., Lewis K., Sutton S., Chan R., Turnbull A. V., Lovejoy D., Rivier C., Rivier J., Sawchenko P. E., Vale W., Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor Nature 1995 378 6554 287 292
16. Okosi A., Brar B. K., Chan M., D'Souza L., Smith E., Stephanou A., Latchman D. S., Chowdrey H. S., Knight R. A., Expression and protective effects of urocortin in cardiac myocytes Neuropeptides 1998 32 2 167 171 (Pubitemid 28212540)
17. Tojo K., Sato S., Tokudome G., Ohta M., Kawaguchi Y., Sakai O., Nakagawa O., Nakao K., Stimulation by corticotropin-releasing factor of atrial natriuretic peptide and brain natriuretic peptide secretions from cultured neonatal rat cardiomyocytes Biochemical and Biophysical Research Communications 1996 225 2 340 346 (Pubitemid 26355605)
18. Ikeda K., Tojo K., Sato S., Ebisawa T., Tokudome G., Hosoya T., Harada M., Nakagawa O., Nakao K., Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes Biochemical and Biophysical Research Communications 1998 250 2 298 304 (Pubitemid 28463872)
19. Cameron V. A., Ellmers L. J., Minireview: natriuretic peptides during development of the fetal heart and circulation Endocrinology 2003 144 6 2191 2194 (Pubitemid 36629865)
20. Kasama S., Furuya M., Toyama T., Ichikawa S., Kurabayashi M., Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction European Heart Journal 2008 29 12 1485 1494 (Pubitemid 351890353)
21. Parkes D. G., Vaughan J., Rivier J., Vale W., May C. N., Cardiac inotropic actions of urocortin in conscious sheep American Journal of Physiology 1997 272 5 H2115 H2122
22. Nishikimi T., Miyata A., Horio T., Yoshihara F., Nagaya N., Takishita S., Yutani C., Matsuo H., Matsuoka H., Kangawa K., Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart American Journal of Physiology 2000 279 6 H3031 H3039
23. Ikeda K., Tojo K., Oki Y., Nakao K., Urocortin has cell-proliferative effects on cardiac non-myocytes Life Sciences 2002 71 16 1929 1938 (Pubitemid 34880237)
24. Brar B. K., Jonassen A. K., Stephanou A., Santilli G., Railson J., Knight R. A., Yellon D. M., Latchman D. S., Urocortin protects against ischemic and reperfusion injury via a MAPK- dependent pathway The Journal of Biological Chemistry 2000 275 12 8508 8514 (Pubitemid 30180198)
25. Scarabelli T. M., Pasini E., Stephanou A., Comini L., Curello S., Raddino R., Ferrari R., Knight R., Latchman D. S., Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion Journal of the American College of Cardiology 2002 40 1 155 161 (Pubitemid 34701391)
26. Kimura Y., Takahashi K., Totsune K., Muramatsu Y., Kaneko C., Darnel A. D., Suzuki T., Ebina M., Nukiwa T., Sasano H., Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart Journal of Clinical Endocrinology and Metabolism 2002 87 1 340 346 (Pubitemid 34084712)
27. Ikeda K., Tojo K., Tokudome G., Ohta M., Sugimoto K. I., Tamura T., Tajima N., Mochizuki S., Kawakami M., Hosoya T., Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases Molecular and Cellular Biochemistry 2003 252 1-2 25 32 (Pubitemid 37220729)
28. Liu C. N., Yang C., Liu X. Y., Li S., In vivo protective effects of urocortin on ischemia-reperfusion injury in rat heart via free radical mechanisms Canadian Journal of Physiology and Pharmacology 2005 83 6 459 465 (Pubitemid 41176363)
29. Meili-Butz S., Bhler K., John D., Buser P., Vale W. W., Peterson K. L., Brink M., Dieterle T., Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure European Journal of Heart Failure 2010 12 8 797 804
30. Charles C. J., Jardine D. L., Rademaker M. T., Richards A. M., Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep Journal of Endocrinology 2010 204 2 181 189
31. Coste S. C., Kesterson R. A., Heldwein K. A., Stevens S. L., Heard A. D., Hollis J. H., Murray S. E., Hill J. K., Pantely G. A., Hohimer A. R., Hatton D. C., Phillips T. J., Finn D. A., Low M. J., Rittenberg M. B., Stenzel P., Stenzel-Poore M. P., Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 Nature Genetics 2000 24 4 403 409 (Pubitemid 30187442)
32. Sztainberg Y., Kuperman Y., Issler O., Gil S., Vaughan J., Rivier J., Vale W., Chen A., A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease The FASEB Journal 2009 23 7 2186 2196
33. Reyes T. M., Lewis K., Perrin M. H., Kunitake K. S., Vaughan J., Arias C. A., Hogenesch J. B., Gulyas J., Rivier J., Vale W. W., Sawchenko P. E., Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2843 2848 (Pubitemid 32209571)
34. Lewis K., Li C., Perrin M. H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T. M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P. E., Vale W. W., Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 7570 7575 (Pubitemid 32567989)
35. Ikeda K., Tojo K., Otsubo C., Udagawa T., Hosoya T., Tajima N., Nakao K., Kawamura M., Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes Peptides 2005 26 12 2473 2481 (Pubitemid 41676719)
36. Chanalaris A., Lawrence K. M., Stephanou A., Knight R. D., Hsu S. Y., Hsueh A. J. W., Latchman D. S., Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes Journal of Molecular and Cellular Cardiology 2003 35 10 1295 1305 (Pubitemid 37163536)
37. Takahashi K., Totsune K., Murakami O., Saruta M., Nakabayashi M., Suzuki T., Sasano H., Shibahara S., Expression of urocortin III/stresscopin in human heart and kidney Journal of Clinical Endocrinology and Metabolism 2004 89 4 1897 1903 (Pubitemid 38507951)
38. Kageyama K., Gaudriault G. E., Bradbury M. J., Vale W. W., Regulation of corticotropin-releasing factor receptor type 2 messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines Endocrinology 2000 141 7 2285 2293 (Pubitemid 32269046)
39. Honjo T., Inoue N., Shiraki R., Kobayashi S., Otsui K., Takahashi M., Hirata K. I., Kawashima S., Yokozaki H., Yokoyama M., Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin Journal of Vascular Research 2006 43 2 131 138 (Pubitemid 43247994)
40. Kageyama K., Furukawa K., Miki I., Terui K., Motomura S., Suda T., Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta Journal of Cardiovascular Pharmacology 2003 42 4 561 565 (Pubitemid 37210872)
41. Sanz E., Fernndez N., Monge L., Climent B., Diéguez G., Garca-Villaln A. L., Relaxation of rat arteries by urocortin: effects of gender and diabetes Journal of Pharmacy and Pharmacology 2003 55 6 783 788 (Pubitemid 36752721)
42. Sanz E., Monge L., Fernndez N., Martnez M. A., Martnez-Len J. B., Diéguez G., Garca-Villaln A. L., Relaxation by urocortin of human saphenous veins British Journal of Pharmacology 2002 136 1 90 94 (Pubitemid 34499320)
43. Xu Y., Zhang R., Chen J., Zhang Q., Wang J., Hu J., Guan X., Jin L., Fu H., Gui B., Guo Y., Li S., Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors British Journal of Pharmacology 2009 157 8 1368 1379
44. Zhang R., Xu Y., Fu H., Wang J., Jin L., Li S., Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin- releasing factor type 2 receptor in rat aortic endothelial cells British Journal of Pharmacology 2009 158 3 819 829
45. Yuan Z., McCauley R., Chen-Scarabelli C., Abounit K., Stephanou A., Barry S. P., Knight R., Saravolatz S. F., Saravolatz L. D., Ulgen B. O., Scarabelli G. M., Faggian G., Mazzucco A., Saravolatz L., Scarabelli T. M., Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection Molecular and Cellular Endocrinology 2010 325 1-2 1 7
46. Kageyama K., Suda T., Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5′-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells Endocrinology 2003 144 6 2234 2241 (Pubitemid 36629872)
47. Brar B. K., Chen A., Perrin M. H., Vale W., Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2 by the CRF/urocortin family of peptides Endocrinology 2004 145 4 1718 1729 (Pubitemid 38402380)
48. Grossini E., Molinari C., Mary D. A., Uberti F., Ribichini F., Caimmi P. P., Vacca G., Urocortin II induces nitric oxide production through cAMP and Ca 2+ related pathways in endothelial cells Cellular Physiology and Biochemistry 2009 23 13 87 96
49. Brar B. K., Stephanou A., Knight R., Latchman D., Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death Journal of Molecular and Cellular Cardiology 2002 34 4 483 492 (Pubitemid 37163462)
50. Lawrence K. M., Kabir A. M., Bellahcene M., Davidson S., Cao X. B., McCormick J., Mesquita R. A., Carroll C. J., Chanalaris A., Townsend P. A., Hubank M., Stephanou A., Knight R. A., Marber M. S., Latchman D. S., Cardioprotection mediated by urocortin is dependent on PKC activation The FASEB Journal 2005 19 7 831 833 (Pubitemid 40617399)
51. Townsend P. A., Davidson S. M., Clarke S. J., Khaliulin I., Carroll C. J., Scarabelli T. M., Knight R. A., Stephanou A., Latchman D. S., Halestrap A. P., Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress American Journal of Physiology 2007 293 2 H928 H938
52. Kageyama K., Hanada K., Nigawara T., Moriyama T., Terui K., Sakihara S., Suda T., Urocortin induces interleukin-6 gene expression via cyclooxygenase-2 activity in aortic smooth muscle cells Endocrinology 2006 147 9 4454 4462 (Pubitemid 44268397)
53. Brar B. K., Jonassen A. K., Egorina E. M., Chen A., Negro A., Perrin M. H., Mjs O. D., Latchman D. S., Lee K. F., Vale W., Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor Type 2 in the murine heart Endocrinology 2004 145 1 24 35 (Pubitemid 38094496)
54. Ng L. L., Loke I. W., O'Brien R. J., Squire I. B., Davies J. E., Plasma urocortin in human systolic heart failure Clinical Science 2004 106 4 383 388 (Pubitemid 38553586)
55. Wilson Tang W. H., Tong W., Shrestha K., Wang Z., Levison B. S., Delfraino B., Hu B., Troughton R. W., Klein A. L., Hazen S. L., Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure European Heart Journal 2008 29 20 2506 2513
56. Phrommintikul A., Sivasinprasasn S., Lailerd N., Chattipakorn S., Kuanprasert S., Chattipakorn N., Plasma urocortin in acute myocardial infarction patients European Journal of Clinical Investigation 2010 40 10 874 882
57. Charles C. J., Rademaker M. T., Richards A. M., Yandle T. G., Plasma urocortin 1 in sheep: regional sampling and effects of experimental heart failure Peptides 2006 27 7 1801 1805 (Pubitemid 43866266)
58. Wright S. P., Doughty R. N., Frampton C. M., Gamble G. D., Yandle T. G., Richards A. M., Plasma urocortin 1 in human heart failure Circulation 2009 2 5 465 471
59. Rademaker M. T., Charles C. J., Espiner E. A., Fisher S., Frampton C. M., Kirkpatrick C. M. J., Lainchbury J. G., Nicholls M. G., Richards A. M., Vale W. W., Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep Journal of the American College of Cardiology 2002 40 8 1495 1505 (Pubitemid 35192877)
60. Bale T. L., Hoshijima M., Gu Y., Dalton N., Anderson K. R., Lee K. F., Rivier J., Chien K. R., Vale W. W., Peterson K. L., The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure Proceedings of the National Academy of Sciences of the United States of America 2004 101 10 3697 3702 (Pubitemid 38338257)
61. Rademaker M. T., Charles C. J., Espiner E. A., Frampton C. M., Lainchbury J. G., Richards A. M., Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure European Heart Journal 2005 26 19 2055 2062 (Pubitemid 41435727)
62. Rademaker M. T., Cameron V. A., Charles C. J., Richards A. M., Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure Circulation 2005 112 23 3624 3632 (Pubitemid 43739541)
63. Rademaker M. T., Cameron V. A., Charles C. J., Richards A. M., Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure European Heart Journal 2006 27 17 2088 2098 (Pubitemid 44412817)
64. Rademaker M. T., Charles C. J., Richards A. M., Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure American Journal of Physiology 2007 293 3 H1536 H1544
65. Davis M. E., Pemberton C. J., Yandle T. G., Fisher S. F., Lainchbury J. G., Frampton C. M., Rademaker M. T., Richards M., Urocortin 2 infusion in human heart failure European Heart Journal 2007 28 21 2589 2597 (Pubitemid 350071510)
66. Rademaker M. T., Charles C. J., Nicholls M. G., Richards A. M., Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure Circulation 2009 2 6 532 540
67. Yang C., Xu Y., Mendez T., Wang F., Yang Q., Li S., Effects of intravenous urocortin on angiotensin-converting enzyme in rats Vascular Pharmacology 2006 44 4 238 246 (Pubitemid 43351183)
68. Yang C., Liu X., Li S., Effect of long-term treatment with urocortin on the activity of somatic angiotensin-converting enzyme in spontaneously hypertensive rats Canadian Journal of Physiology and Pharmacology 2010 88 2 168 176
69. Davis M. E., Pemberton C. J., Yandle T. G., Fisher S. F., Lainchbury J. G., Frampton C. M., Rademaker M. T., Richards A. M., Urocortin 2 infusion in healthy humans. hemodynamic, neurohormonal, and renal responses Journal of the American College of Cardiology 2007 49 4 461 471 (Pubitemid 46135883)